Pharmaceuticals, Biotechnology and Life Sciences
A first-in-kind tool that collects and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation. Based on…
A first-in-kind tool that collects and analyzes continuous physiologic data could provide early clinical indicators of COVID-19 decompensation. Based on…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary antibody therapeutics intended to engage the immune system to…
Latest product introduction continues to validate platform modularity and enables company to meet increasing customer demand BERKELEY, Calif.–(BUSINESS WIRE)–Lygos, Inc.,…
Latest product introduction continues to validate platform modularity and enables company to meet increasing customer demand BERKELEY, Calif.–(BUSINESS WIRE)–Lygos, Inc.,…
Latest product introduction continues to validate platform modularity and enables company to meet increasing customer demand BERKELEY, Calif.–(BUSINESS WIRE)–Lygos, Inc.,…